Fife Brian T, Pauken Kristen E, Eagar Todd N, Obu Takashi, Wu Jenny, Tang Qizhi, Azuma Miyuki, Krummel Matthew F, Bluestone Jeffrey A
UCSF Diabetes Center, Department of Medicine, University of California, San Francisco, California, USA.
Nat Immunol. 2009 Nov;10(11):1185-92. doi: 10.1038/ni.1790. Epub 2009 Sep 27.
Programmed death 1 (PD-1) is an inhibitory molecule expressed on activated T cells; however, the biological context in which PD-1 controls T cell tolerance remains unclear. Using two-photon laser-scanning microscopy, we show here that unlike naive or activated islet antigen-specific T cells, tolerized islet antigen-specific T cells moved freely and did not swarm around antigen-bearing dendritic cells (DCs) in pancreatic lymph nodes. Inhibition of T cell antigen receptor (TCR)-driven stop signals depended on continued interactions between PD-1 and its ligand, PD-L1, as antibody blockade of PD-1 or PD-L1 resulted in lower T cell motility, enhanced T cell-DC contacts and caused autoimmune diabetes. Blockade of the immunomodulatory receptor CTLA-4 did not alter T cell motility or abrogate tolerance. Thus, PD-1-PD-L1 interactions maintain peripheral tolerance by mechanisms fundamentally distinct from those of CTLA-4.
程序性死亡蛋白1(PD-1)是一种在活化T细胞上表达的抑制性分子;然而,PD-1控制T细胞耐受性的生物学背景仍不清楚。利用双光子激光扫描显微镜,我们在此表明,与未活化或活化的胰岛抗原特异性T细胞不同,耐受的胰岛抗原特异性T细胞能自由移动,且不会在胰腺淋巴结中围绕携带抗原的树突状细胞(DC)聚集。T细胞抗原受体(TCR)驱动的停止信号的抑制取决于PD-1与其配体PD-L1之间的持续相互作用,因为对PD-1或PD-L1的抗体阻断会导致T细胞运动性降低、T细胞与DC的接触增强,并引发自身免疫性糖尿病。免疫调节受体CTLA-4的阻断不会改变T细胞运动性或消除耐受性。因此,PD-1-PD-L1相互作用通过与CTLA-4根本不同的机制维持外周耐受性。